Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2024/02/26
-
Journal
-
Indian UGC (journal)
-
Refrences39
-
Citations1
-
Chenyu Zhao
-
Yunyuan Yu
-
Guangrong Yin
-
Chao Xu
-
Jiahao Wang
-
Liangliang Wang
-
Gongyin Zhao
-
Su Ni
-
Haoxing Zhang
-
Baojun Zhou
-
Yuji Wang ORCID (unauthenticated)
Abstract
Cite
Zhao, Chenyu, et al. “Sulfasalazine Promotes Ferroptosis through AKT-ERK1 2 and P53-SLC7A11 in Rheumatoid Arthritis”. Inflammopharmacology, vol. 32, no. 2, 2024, pp. 1277-94, https://doi.org/10.1007/s10787-024-01439-6.
Zhao, C., Yu, Y., Yin, G., Xu, C., Wang, J., Wang, L., Zhao, G., Ni, S., Zhang, H., Zhou, B., & Wang, Y. (2024). Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis. Inflammopharmacology, 32(2), 1277-1294. https://doi.org/10.1007/s10787-024-01439-6
Zhao, Chenyu, Yunyuan Yu, Guangrong Yin, Chao Xu, Jiahao Wang, Liangliang Wang, Gongyin Zhao, et al. “Sulfasalazine Promotes Ferroptosis through AKT-ERK1 2 and P53-SLC7A11 in Rheumatoid Arthritis”. Inflammopharmacology 32, no. 2 (2024): 1277-94. https://doi.org/10.1007/s10787-024-01439-6.
Zhao C, Yu Y, Yin G, Xu C, Wang J, Wang L, et al. Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis. Inflammopharmacology. 2024;32(2):1277-94.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Synergy research: Approaching a new generation of phytopharmaceuticals
- Synergy and other interactions in phytomedicines
- Synergism between natural products and antibiotics against infectious diseases
- Cisplatin in cancer therapy: Molecular mechanisms of action
- Behavioural despair in rats: A new model sensitive to antidepressant treatments
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Glycine increased ferroptosis via SAM-mediated GPX4 promoter methylation in rheumatoid arthritis | Rheumatology |
| 36 | 2022 |
Diosmin and Trolox Have Anti-Arthritic, Anti-Inflammatory and Antioxidant Potencies in Complete Freund’s Adjuvant-Induced Arthritic Male Wistar Rats: Roles of NF-κB, iNOS, Nrf2 and MMPs | Antioxidants |
| 10 | 2022 |
| Synthesis and anti-rheumatoid arthritis activities of 3-(4-aminophenyl)-coumarin derivatives | Journal of Enzyme Inhibition and Medicinal Chemistry |
| 15 | 2021 |
Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use | Journal of Cellular and Molecular Medicine |
| 11 | 2021 |
| Glutathione peroxidase 4–regulated neutrophil ferroptosis induces systemic autoimmunity | Nature Immunology |
| 182 | 2021 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy 12
is the most frequently represented among the references in this article. It primarily includes studies from Frontiers in Immunology and Cell. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Effect of sulfasalazine on ferroptosis during intestinal injury in rats after liver transplantation | Scientific Reports |
| 2024 |
Citations Analysis
| Category | Category Repetition |
|---|---|
| Medicine | 1 |
| Science | 1 |
| Science: Science (General) | 1 |
The category
Medicine 1
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Effect of sulfasalazine on ferroptosis during intestinal injury in rats after liver transplantation and was published in 2024. The most recent citation comes from a 2024 study titled Effect of sulfasalazine on ferroptosis during intestinal injury in rats after liver transplantation. This article reached its peak citation in 2024, with 1 citations. It has been cited in 1 different journals, 100% of which are open access. Among related journals, the Scientific Reports cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.